Overview Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers Status: Completed Trial end date: 1999-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the multiple-dose pharmacokinetic characteristics and pharmacologic activity of gemcabene. Phase: Phase 1 Details Lead Sponsor: Gemphire Therapeutics, Inc.NeuroBo Pharmaceuticals Inc.